Specifically, this subset exhibited a decreasing trend in its proportion within the disease groups compared to the healthy controls ( Figure 3D ).
← all excerpts
Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet's disease and inflammatory bowel disease.
1
—
—